Enzyme Engineering
Open Access

The Impact of Rational Design on Biomedical Research

Yazdan Asgari^{* *}Correspondence: Yazdan Asgari, Department of Organic Chemistry, University of Science and Technology, Lausanne, Switzerland, Email:

Author info »

Description

Rational design is a methodical approach in the fields of biotechnology, chemistry and materials science that involves the intentional design of molecules, proteins and materials with specific, desired properties. Unlike methods that depend on trial and error, rational design uses a detailed understanding of the relationships between structure and function to predict and create new functionalities [1]. This technique has revolutionized various fields, particularly in the development of pharmaceuticals, industrial enzymes and nanomaterials. Advances in gene editing technologies allow for precise modifications of genetic material, enabling the rational design of organisms with desired traits for applications in medicine, agriculture and bioenergy.

Principles of rational design

Rational design is grounded in the knowledge of molecular structure and the mechanisms by which molecules interact and react [2]. The key principles include:

Structural understanding: Knowing the three-dimensional structure of the target molecule or material is important. Techniques like X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy and cryo-electron microscopy provide detailed structural data.

Mechanistic insight: Understanding the mechanisms of action, such as how a protein catalyzes a reaction or how a drug interacts with its target, allows for the prediction of how modifications will affect function.

Computational tools: Advanced computational methods, including molecular dynamics simulations, quantum mechanics calculations and bioinformatics tools, enable the modeling and prediction of molecular behavior and interactions [3].

Drug development

One of the most impactful applications of rational design is in the development of pharmaceuticals [4]. By understanding the structure of biological targets such as enzymes, receptors or nucleic acids, researchers can design drugs that bind specifically and effectively.

Targeted therapy: Rational design enables the creation of drugs that target specific proteins involved in diseases. For instance, the design of kinase inhibitors for cancer treatment relies on detailed knowledge of the kinase active site [5].

Antiviral drugs: The design of inhibitors for viral enzymes, such as proteases and polymerases, has led to effective treatments for diseases like Human Immuno Virus (HIV) and hepatitis C [6].

Enzyme engineering

Enzymes are nature's catalysts and their engineering through rational design has significant industrial and environmental applications.

Biocatalysts: Designed enzymes can perform specific chemical reactions with high efficiency and selectivity, useful in the synthesis of pharmaceuticals, biofuels and fine chemicals [7].

Stability and activity: Rational design can enhance the stability of enzymes under industrial conditions (e.g., high temperature, extreme pH) and increase their catalytic activity [8].

Protein therapeutics

Rational design is employed to enhance the efficacy, specificity and stability of therapeutic proteins, such as antibodies and cytokines.

Antibodies: Engineered antibodies can be designed to bind tightly to antigens on cancer cells, improving the targeting and killing of these cells while minimizing side effects [9].

Cytokines: Modifying cytokines can enhance their therapeutic potential in immune modulation, making treatments for autoimmune diseases and cancer more effective [10].

Conclusion

Rational design represents a paradigm shift from empirical to predictive science, enabling the creation of molecules, proteins and materials with unprecedented precision. By leveraging structural and mechanistic insights, computational tools and iterative optimization, rational design has made significant contributions to drug development, enzyme engineering and material science. Despite the challenges, the integration of new technologies and interdisciplinary approaches assure to further enhance the capabilities and applications of rational design. As this field continues to evolve, it will undoubtedly play a pivotal role in addressing some of the most pressing challenges in healthcare, industry and the environment. Rational design is a foundation of synthetic biology, where it is used to construct new biological systems and redesign existing ones for useful purposes, such as creating biosensors or producing renewable chemicals.

References

1. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262-1278.

   [Crossref] [Google Scholar] [PubMed]

2. Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly (ethylene imine) and its derivatives. J Gene Med. 2005;7(8):992-1009.

   [Crossref] [Google Scholar] [PubMed]

3. Aminpour M, Montemagno C, Tuszynski JA. An overview of molecular modeling for drug discovery with specific illustrative examples of applications. Molecules. 2019;24(9):1693.

   [Crossref] [Google Scholar] [PubMed]

4. Milligan PA, Brown MJ, Marchant B, Martin SW, van Der Graaf PH, Benson N, et al. Model‐based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol Ther. 2013;93(6):502-514.

   [Crossref] [Google Scholar] [PubMed]

5. Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11(3):2313-2381.

   [Crossref] [Google Scholar] [PubMed]

6. Daniell H, Lin CS, Yu M, Chang WJ. Chloroplast genomes: diversity, evolution, and applications in genetic engineering. Genome Biol. 2016;17(1):134.

   [Crossref] [Google Scholar] [PubMed]

7. Lam E, Luong JH. Carbon materials as catalyst supports and catalysts in the transformation of biomass to fuels and chemicals. ACS catalysis. 2014;4(10):3393-3410.

   [Crossref] [Google Scholar]

8. Arrizubieta MJ, Polaina J. Increased thermal resistance and modification of the catalytic properties of a β-glucosidase by random mutagenesis and in vitro recombination. J Biol Chem. 2000;275(37):28843-28848. 

   [Crossref] [Google Scholar] [PubMed]

9. Giuliani A, Pirri G, Nicoletto S. Antimicrobial peptides: an overview of a promising class of therapeutics. Open Life Sci. 2007;2(1):1-33.

   [Crossref] [Google Scholar]

10. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2(4):MR17-MR71.

    [Crossref] [Google Scholar] [PubMed]